{"altmetric_id":26571113,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":7},"twitter":{"unique_users_count":6,"unique_users":["docmikejd","DrRaulCordoba","BloodJournal","ChrisBoatner","maljurf100","AndreGoyMD"],"posts_count":7}},"selected_quotes":["Inside Blood Commentary: Expanding and expounding the genomic map of CTCL","Genomic data has begun to shed light on mutational landscape of CTCL. This expands expounds on that","Expanding and expounding the genomic map of #CTCL #lymphoma #lymsm #dermpath #hemepath"],"citation":{"altmetric_jid":"4f6fa60e3cf058f610006cba","authors":["Anjali Mishra","Pierluigi Porcu"],"doi":"10.1182\/blood-2017-08-797399","first_seen_on":"2017-09-26T00:34:14+00:00","funders":["niehs"],"handles":[],"issns":["0006-4971","1528-0020"],"issue":"12","journal":"Blood","last_mentioned_on":1506699900,"links":["http:\/\/www.bloodjournal.org\/content\/130\/12\/1389?sso-checked=true&utm_content=bufferff837&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer","http:\/\/www.bloodjournal.org\/content\/130\/12\/1389?sso-checked=true"],"pdf_url":"http:\/\/www.bloodjournal.org\/content\/bloodjournal\/130\/12\/1389.full.pdf","pmid":"28935641","pubdate":"2017-09-21T00:00:00+00:00","publisher":"American Society of Hematology","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"},{"name":"Clinical Sciences","scheme":"era"},{"name":"Paediatrics And Reproductive Medicine","scheme":"era"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Immunology and Microbiology","Biochemistry, Genetics and Molecular Biology"],"subjects":["hematology"],"title":"Expanding and expounding the genomic map of CTCL","type":"article","volume":"130"},"altmetric_score":{"score":3.1,"score_history":{"1y":3.1,"6m":3.1,"3m":3.1,"1m":3.1,"1w":2.1,"6d":0.5,"5d":0.5,"4d":0.5,"3d":0,"2d":0,"1d":0,"at":3.1},"context_for_score":{"all":{"total_number_of_other_articles":8462498,"mean":7.1083922572655,"rank":2152725,"this_scored_higher_than_pct":74,"this_scored_higher_than":6289173,"rank_type":"exact","sample_size":8462498,"percentile":74},"similar_age_3m":{"total_number_of_other_articles":114692,"mean":11.472705007368,"rank":34262,"this_scored_higher_than_pct":69,"this_scored_higher_than":79906,"rank_type":"exact","sample_size":114692,"percentile":69},"this_journal":{"total_number_of_other_articles":9865,"mean":5.7786729521492,"rank":2901,"this_scored_higher_than_pct":70,"this_scored_higher_than":6930,"rank_type":"exact","sample_size":9865,"percentile":70},"similar_age_this_journal_3m":{"total_number_of_other_articles":68,"mean":6.3392537313433,"rank":36,"this_scored_higher_than_pct":47,"this_scored_higher_than":32,"rank_type":"exact","sample_size":68,"percentile":47}}},"demographics":{"poster_types":{"member_of_the_public":3,"practitioner":2,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":3,"Practitioners (doctors, other healthcare professionals)":2,"Science communicators (journalists, bloggers, editors)":1}}},"geo":{"twitter":{"AU":1,"ES":1,"US":2,"SA":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/docmikejd\/statuses\/912475308292493312","license":"gnip","citation_ids":[26571113],"posted_on":"2017-09-26T00:34:01+00:00","author":{"name":"Michael Dickinson","url":"https:\/\/www.petermac.org\/users\/dr-michael-dickinson","image":"https:\/\/pbs.twimg.com\/profile_images\/907046711901659137\/kt9C9UFU_normal.jpg","description":"Clinical haematologist at Peter MacCallum Cancer Centre in Melbourne. Aggressive Lymphoma Lead. MDS\/AML\/myeloma.Early phase trials. Views are my own.","id_on_source":"docmikejd","tweeter_id":"27204938","geo":{"lt":-37.83333,"ln":144.96667,"country":"AU"},"followers":183},"tweet_id":"912475308292493312"},{"url":"http:\/\/twitter.com\/DrRaulCordoba\/statuses\/912552984676044800","license":"gnip","citation_ids":[26571113],"posted_on":"2017-09-26T05:42:40+00:00","author":{"name":"Raul Cordoba","url":"http:\/\/www.fjd.es","image":"https:\/\/pbs.twimg.com\/profile_images\/817087500850229248\/LRpwr7_9_normal.jpg","description":"\ud83c\uddea\ud83c\uddf8Mi Vocaci\u00f3n? La Medicina. Mi Pasi\u00f3n? La Hematolog\u00eda. Mi especialidad? Los Linfomas \ud83c\uddfa\ud83c\uddf8Doctor. Hematologist. Interest in #lymphoma #CLL #gerionc #ImmunoOnc","id_on_source":"DrRaulCordoba","tweeter_id":"1697360292","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":2032},"tweet_id":"912552984676044800"},{"url":"http:\/\/twitter.com\/BloodJournal\/statuses\/912761301771763712","license":"gnip","citation_ids":[26571113],"posted_on":"2017-09-26T19:30:27+00:00","author":{"name":"Blood Journal","url":"http:\/\/www.bloodjournal.org","image":"https:\/\/pbs.twimg.com\/profile_images\/669620689461248000\/x443s9OU_normal.jpg","description":"Blood, the official journal of @ASH_Hematology, is the most cited peer-reviewed publication in the field of hematology, available weekly in print and online.","id_on_source":"BloodJournal","tweeter_id":"3407436940","geo":{"lt":null,"ln":null},"followers":8040},"tweet_id":"912761301771763712"},{"url":"http:\/\/twitter.com\/DrRaulCordoba\/statuses\/912764471839543296","license":"gnip","rt":["BloodJournal"],"citation_ids":[26571113],"posted_on":"2017-09-26T19:43:03+00:00","author":{"name":"Raul Cordoba","url":"http:\/\/www.fjd.es","image":"https:\/\/pbs.twimg.com\/profile_images\/817087500850229248\/LRpwr7_9_normal.jpg","description":"\ud83c\uddea\ud83c\uddf8Mi Vocaci\u00f3n? La Medicina. Mi Pasi\u00f3n? La Hematolog\u00eda. Mi especialidad? Los Linfomas \ud83c\uddfa\ud83c\uddf8Doctor. Hematologist. Interest in #lymphoma #CLL #gerionc #ImmunoOnc","id_on_source":"DrRaulCordoba","tweeter_id":"1697360292","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":2032},"tweet_id":"912764471839543296"},{"url":"http:\/\/twitter.com\/ChrisBoatner\/statuses\/912773947430772737","license":"gnip","rt":["BloodJournal"],"citation_ids":[26571113],"posted_on":"2017-09-26T20:20:42+00:00","author":{"name":"BMTRegNurse","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000833482537\/29c983490629b426277863f4b2b92fb3_normal.jpeg","id_on_source":"ChrisBoatner","tweeter_id":"2209162186","geo":{"lt":33.47097,"ln":-81.97484,"country":"US"},"followers":55},"tweet_id":"912773947430772737"},{"url":"http:\/\/twitter.com\/maljurf100\/statuses\/912791834669338625","license":"gnip","rt":["BloodJournal"],"citation_ids":[26571113],"posted_on":"2017-09-26T21:31:46+00:00","author":{"name":"Mahmoud Aljurf","image":"https:\/\/pbs.twimg.com\/profile_images\/913142811368751104\/fLvOXEkK_normal.jpg","description":"Hematology\/HSCT Program - King Faisal Specialist Hospital & Research Center. Riyadh- Saudi Arabia. #bmtsm #Leusm #BMFSM","id_on_source":"maljurf100","tweeter_id":"835587356812062720","geo":{"lt":24.68773,"ln":46.72185,"country":"SA"},"followers":167},"tweet_id":"912791834669338625"},{"url":"http:\/\/twitter.com\/AndreGoyMD\/statuses\/913791731761651717","license":"gnip","citation_ids":[26571113],"posted_on":"2017-09-29T15:45:00+00:00","author":{"name":"Dr. Andre Goy","url":"http:\/\/www.jtcancercenter.org\/physician\/andre-goy\/","image":"https:\/\/pbs.twimg.com\/profile_images\/664112200064172032\/a48t2J7I_normal.jpg","description":"Chairman and Director of @JTCancerCenter @HackensackUMC and Chief of Lymphoma","id_on_source":"AndreGoyMD","tweeter_id":"73166720","geo":{"lt":40.88593,"ln":-74.04347,"country":"US"},"followers":665},"tweet_id":"913791731761651717"}]}}